Shinya Uchida
Overview
Explore the profile of Shinya Uchida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakano Y, Miura M, Namiki N, Uchida S
Chem Pharm Bull (Tokyo)
. 2024 Nov;
72(11):936-943.
PMID: 39496399
Orally disintegrating tablets (ODTs) can be easily swallowed without drinking water and are a convenient dosage form for the elderly and infirmed patients, as well as other patients, such as...
2.
Miura M, Kojima S, Tanaka S, Kashiwagura Y, Namiki N, Uchida S
Int J Clin Pharmacol Ther
. 2024 May;
62(8):353-362.
PMID: 38699974
Objective: Visual analog scale (VAS) can be used to evaluate multiple parameters. There have been no reports on the verification of order effects or reproducibility of the VAS method for...
3.
Suzuki H, Yamauchi K, Uchida S
Clin Case Rep
. 2024 Mar;
12(3):e8638.
PMID: 38464584
Severe pruritus in a hemodialysis patient who had difficulty applying topical medication markedly reduced with the use of bath preparation containing rice extract. The bath preparation could be effective and...
4.
Todoroki K, Fukudo N, Kudoh Y, Mizuno H, Min J, Tanaka S, et al.
Anal Sci
. 2024 Feb;
40(5):863-869.
PMID: 38358581
We report on the development of an on-site therapeutic drug monitoring (TDM) method for vancomycin (VCM) utilizing a portable spectrometer and commercially available immunoturbidimetric assay reagents designed for automated clinical...
5.
Kawamoto S, Tanaka S, Miura M, Kashiwagura Y, Kamiya C, Hakamata A, et al.
Chem Pharm Bull (Tokyo)
. 2023 May;
71(6):441-446.
PMID: 37258198
Good adherence to medication is critical for successfully treating psychiatric disorders. Tailor-made pharmaceutical formulations can provide a suitable dosage form to meet the specific needs of individual patients who exhibit...
6.
Kashiwagura Y, Takusagawa S, Ikematsu Y, Tanaka S, Namiki N, Uchida S
Acta Pharm
. 2023 Jan;
73(1):107-119.
PMID: 36692467
This study aimed to elucidate the characteristics and pharmacokinetics of orally disintegrating tablets (ODTs) containing coenzyme Q10 (CoQ10) granules prepared by spray drying, hot-melting, and wet granulation. The hardness and...
7.
Nagata E, Kashiwagura Y, Okada E, Tanaka S, Sano S, Nishida M, et al.
J Pharmacol Sci
. 2022 May;
149(2):60-65.
PMID: 35512856
Infantile hemangioma (IH) is a common tumor in infants that gradually resolves and is often untreated. However, for cosmetic reasons, parents often opt for treatment. Oral propranolol, the first-line therapy...
8.
Uchida S, Kikuya M, Asayama K, Ohata C, Kimura T, Tatsumi Y, et al.
Hypertens Res
. 2022 Apr;
45(7):1222.
PMID: 35440808
No abstract available.
9.
Kashiwagura Y, Hakamata A, Shirai M, Endoh A, Tanaka S, Inui N, et al.
Chem Pharm Bull (Tokyo)
. 2022 Apr;
70(4):277-282.
PMID: 35370204
Propranolol is used as the first-line treatment for infantile hemangiomas (IHs). As oral formulations can cause systemic adverse drug reactions (ADRs), we prepared topical propranolol formulations and evaluated their pharmaceutical...
10.
Uchida S, Kikuya M, Asayama K, Ohata C, Kimura T, Tatsumi Y, et al.
Hypertens Res
. 2022 Feb;
45(4):722-729.
PMID: 35177788
The predictive power of home blood pressure (BP) in the evening compared with home BP in the morning and office BP has been controversial. The predictive power of evening BP...